A novel Ca²+ channel antagonist reverses cardiac hypertrophy and pulmonary arteriolar remodeling in experimental pulmonary hypertension

Autor: Pereira, Sharlene Lopes1 sharlene.pereira@yahoo.com.br, Kummerle, Arthur Eugen2 akummerle@yahoo.com.br, Fraga, Carlos Alberto Manssour1,3 cmfraga@ccsdecania.ufrj.br, Barreiro, Eliezer Jesus1,3 ejbarreiro@ccsdecania.ufrj.br, Rocha, Nazareth de Novaes4 nn_rocha@hotmail.com, Ferraz, Emanuelle Baptista5 manufisio07@hotmail.com, Nascimento, José Hamilton Matheus do5 jhmn@biof.ufrj.br, Sudo, Roberto Takashi1,3 rtsudo@icb.ufrj.br, Zapata-Sudo, Gisele1,3 gsudo@icb.ufrj.br
Zdroj: European Journal of Pharmacology. Feb2013, Vol. 702 Issue 1-3, p316-322. 7p.
Databáze: Academic Search Ultimate
Externí odkaz: